Literature DB >> 322507

The differential mobilization of human neutrophil granules. Effects of phorbol myristate acetate and ionophore A23187.

D G Wright, D A Bralove, J I Gallin.   

Abstract

Phorbol myristate acetate (PMA, 2 to 100 ng/ml) and ionophore A23187 (10(-7) to 10(-6) M) cause human neutrophils to release up to 50% of the granule-associated enzyme lysozyme extracellularly without release of beta-glucuronidase or the cytoplasmic enzyme LDH. When azurophil and specific granules are separated from neutrophil lysates by sucrose density centrifugation, it is found that lysozyme release from neutrophils exposed to PMA or to A23187 reflects a selective disappearance of the small, peroxidase-negative (specific) granules from the cells. These studies demonstrate that neutrophils can mobilize the specific and azurophil granules independently. These studies also demonstrate that under certain conditions the specific granules of human neutrophils behave like the storage granules of secretory cells. Finally, these studies show that techniques of separating neutrophil granules according to their sedimentation characteristics successfully divide these granules into populations that are distinct not only by cytochemical and morphologic criteria but also according to their availability for mobilization and extracellular release. (APM J Pathol 87:273-284, 1977).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 322507      PMCID: PMC2032029     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  16 in total

1.  Fine structural studies on the development of heterophil, eosinophil, and basophil granulocytes in rabbits.

Authors:  B K Wetzel; R G Horn; S S Spicer
Journal:  Lab Invest       Date:  1967-03       Impact factor: 5.662

2.  Mechanism of release of norepinephrine from peripheral adrenergic neurones by the calcium ionophores X 537A and A 23187.

Authors:  N B Thoa; J L Costa; J Moss; I J Kopin
Journal:  Life Sci       Date:  1974-05-01       Impact factor: 5.037

3.  Character of azurophil and specific granules purified from human polymorphonuclear leukocytes.

Authors:  J K Spitznagel; F G Dalldorf; M S Leffell; J D Folds; I R Welsh; M H Cooney; L E Martin
Journal:  Lab Invest       Date:  1974-06       Impact factor: 5.662

4.  Induction of enzyme secretion in rat pancreatic slices using the ionophore A-23187 and calcium. An experimental bypass of the hormone receptor pathway.

Authors:  S Eimerl; N Savion; O Heichal; Z Selinger
Journal:  J Biol Chem       Date:  1974-06-25       Impact factor: 5.157

5.  Specific degranulation of human polymorphonuclear leukocytes.

Authors:  R D Estensen; J G White; B Holmes
Journal:  Nature       Date:  1974-03-22       Impact factor: 49.962

6.  Intracellular and extracellular degranulation of human polymorphonuclear azurophil and specific granules induced by immune complexes.

Authors:  M S Leffell; J K Spitznagel
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

7.  Separation and characterization of human neutrophil granules.

Authors:  B C West; A S Rosenthal; N A Gelb; H R Kimball
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

8.  Selective labilization of specific granules in polymorphonuclear leukocytes by phorbol myristate acetate.

Authors:  J G White; R D Estensen
Journal:  Am J Pathol       Date:  1974-04       Impact factor: 4.307

9.  Calcium-induced extrusion of secretory granules (exocytosis) in mast cells exposed to 48-80 or the ionophores A-23187 and X-537A.

Authors:  D E Cochrane; W W Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

10.  The development of neutrophilic polymorphonuclear leukocytes in human bone marrow.

Authors:  D F Bainton; J L Ullyot; M G Farquhar
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more
  31 in total

1.  Defensins impair phagocytic killing by neutrophils in biomaterial-related infection.

Authors:  S S Kaplan; R P Heine; R L Simmons
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Leukocytic cell sources of airway tissue kallikrein.

Authors:  Isabel T Lauredo; Rosanna M Forteza; Yelena Botvinnikova; William M Abraham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-12-05       Impact factor: 5.464

Review 3.  Lysosomal enzymes of phagocytes and the mechanism of their release.

Authors:  M Ferencík; J Stefanovic
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

4.  Separation and function of neutrophil karyogranuloplasts and comparison with cytoplasts and intact cells.

Authors:  Y Ohno; J Falloon; B E Seligmann; J Nath; M M Friedman; J I Gallin
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

5.  Mobilization of sialidase from intracellular stores to the surface of human neutrophils and its role in stimulated adhesion responses of these cells.

Authors:  A S Cross; D G Wright
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Chédiak-Higashi syndrome neutrophils are characterized by the absence of both normal azurophilic granules.

Authors:  B C West
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

7.  Regulation of phosphatidylinositol turnover, calcium metabolism and enzyme secretion by phorbol dibutyrate in neutrophils.

Authors:  C M Kramer; R C Franson; R P Rubin
Journal:  Lipids       Date:  1984-05       Impact factor: 1.880

8.  Role of hydrogen peroxide in the neutrophil-mediated release of prostacyclin from cultured endothelial cells.

Authors:  J M Harlan; K S Callahan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Human leukocytic pyrogen induces release of specific granule contents from human neutrophils.

Authors:  M S Klempner; C A Dinarello; J I Gallin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  Role of secretory events in modulating human neutrophil chemotaxis.

Authors:  J I Gallin; D G Wright; E Schiffmann
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.